Related Experiment Video
Updated: Aug 7, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Mood and sleep in Parkinson's disease
Leora L Borek1, Robert Kohn, Joseph H Friedman
1Department of Psychiatry and Human Behavior, Butler Hospital. Leolisa@yahoo.com
The Journal of Clinical Psychiatry
|July 20, 2006
Summary
Depression and anxiety significantly correlate with sleep disturbances, including poor sleep quality, nightmares, and daytime sleepiness, in Parkinson's disease patients. Addressing these mental health conditions is crucial for improving patient quality of life.
Area of Science:
- Neurology
- Sleep Medicine
- Psychiatry
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder impacting motor function.
- Sleep disturbances are common in PD patients, affecting their quality of life.
- The relationship between the severity of depression and anxiety and specific sleep issues in PD requires further investigation.
Purpose of the Study:
- To investigate the association between the severity of depression and anxiety and specific types of sleep disturbances in patients diagnosed with Parkinson's disease.
Main Methods:
- 120 idiopathic Parkinson's disease patients were recruited.
- Standardized scales (Hamilton Rating Scale for Depression/Anxiety, Covi Anxiety Scale, PSQI, ESS) were used for assessment.
- Nightmares and REM sleep behavior disorder (RBD) were evaluated using questionnaires and dream logs.
Main Results:
- Depression and anxiety severity significantly correlated with poor sleep quality, daytime somnolence, and nightmares.
- Depression severity explained variance in poor sleep quality and nightmares.
- Anxiety severity explained variance in daytime somnolence.
Conclusions:
- Depressive and anxiety symptoms are linked to sleep disturbances in Parkinson's disease patients.
- Screening for depression and anxiety in PD patients with sleep disorders is recommended.
- Treating depression and anxiety can improve the quality of life for individuals with Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:15REM Sleep Behavior Disorder
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...